Massimo Lisot
Chief Executive Officer at Kering Eyewear DACH GmbH
Profile
Massimo Lisot is currently the Co-Managing Director at Kering Eyewear DACH GmbH.
Previously, he worked as the Director of Business Development at Safilo Group SpA and as a Corporate Finance Manager at Morgan Stanley International Ltd.
He obtained an undergraduate degree from the University of Udine.
Massimo Lisot active positions
| Companies | Position | Start |
|---|---|---|
Kering Eyewear DACH GmbH
 Kering Eyewear DACH GmbH Medical SpecialtiesHealth Technology Part of Kering SA, Kering Eyewear DACH GmbH manufactures medical devices. The company is based in Munich, Germany. The CEOs of the German company are Massimo Lisot, Anna Zurlo, Sergio Gonella. | Chief Executive Officer | - |
Former positions of Massimo Lisot
| Companies | Position | End |
|---|---|---|
Morgan Stanley International Ltd.
 Morgan Stanley International Ltd. Investment Banks/BrokersFinance Morgan Stanley International Ltd. provides diversified financial services abroad. The company is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
| SAFILO GROUP S.P.A. | Corporate Officer/Principal | - |
Training of Massimo Lisot
| University of Udine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SAFILO GROUP S.P.A. | Health Technology |
| Private companies | 2 |
|---|---|
Morgan Stanley International Ltd.
Morgan Stanley International Ltd. Investment Banks/BrokersFinance Morgan Stanley International Ltd. provides diversified financial services abroad. The company is headquartered in London, the United Kingdom. | Finance |
Kering Eyewear DACH GmbH
Kering Eyewear DACH GmbH Medical SpecialtiesHealth Technology Part of Kering SA, Kering Eyewear DACH GmbH manufactures medical devices. The company is based in Munich, Germany. The CEOs of the German company are Massimo Lisot, Anna Zurlo, Sergio Gonella. | Health Technology |
- Stock Market
- Insiders
- Massimo Lisot
